Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 09:31, 5 May 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

4 May 2024

 m   21:56  Gestational trophoblastic neoplasia‎‎ 2 changes history +625 [Jwarner‎ (2×)]
 m   
21:56 (cur | prev) +409 Jwarner talk contribs →‎EMA-CO {{#subobject:418f07|Regimen=1}}
 m   
21:51 (cur | prev) +216 Jwarner talk contribs →‎Mercaptopurine & Methotrexate {{#subobject:d34408|Regimen=1}}
 m   13:05  Rhabdomyosarcoma‎‎ 2 changes history +442 [Jwarner‎ (2×)]
 m   
13:05 (cur | prev) +151 Jwarner talk contribs →‎All lines of therapy
 m   
13:03 (cur | prev) +291 Jwarner talk contribs →‎VA {{#subobject:a9710b|Regimen=1}}
 m   01:09  Hereditary hemorrhagic telangiectasia‎‎ 4 changes history +442 [Jwarner‎ (4×)]
 m   
01:09 (cur | prev) -18 Jwarner talk contribs →‎Tranexamic acid monotherapy {{#subobject:ea894c|Regimen=1}}
 m   
01:07 (cur | prev) +44 Jwarner talk contribs →‎References
 m   
01:06 (cur | prev) +268 Jwarner talk contribs →‎Tranexamic acid monotherapy {{#subobject:ea894c|Regimen=1}}
 m   
01:01 (cur | prev) +148 Jwarner talk contribs →‎Tamoxifen monotherapy {{#subobject:b1894c|Regimen=1}}
     00:59  Hepatoblastoma‎‎ 5 changes history +4,916 [Jwarner‎ (5×)]
 m   
00:59 (cur | prev) +152 Jwarner talk contribs →‎Neoadjuvant therap
 m   
00:57 (cur | prev) +2,484 Jwarner talk contribs →‎Adjuvant therapy
 m   
00:56 (cur | prev) -2,461 Jwarner talk contribs →‎Cisplatin monotherapy {{#subobject:ea894c|Regimen=1}}
 m   
00:55 (cur | prev) +58 Jwarner talk contribs →‎COG AHEP0731 protocol H - non-responders {{#subobject:3a882f|Regimen=1}}
     
00:54 (cur | prev) +4,683 Jwarner talk contribs →‎SIOPEL-4 protocol {{#subobject:3a6ad9|Regimen=1}}

3 May 2024

 m   20:50  Extranodal NK- and T-cell lymphoma, nasal type diffhist +154 Jwarner talk contribs →‎DEP & RT {{#subobject:d8a9eb|Regimen=1}}
 m   20:33  Rhabdomyosarcoma, pediatric diffhist -182 Jwarner talk contribs
 m   20:27  Classical Hodgkin lymphoma‎‎ 2 changes history -1,252 [Jwarner‎ (2×)]
 m   
20:27 (cur | prev) -1,368 Jwarner talk contribs →‎VEBEP {{#subobject:d7a2a6|Regimen=1}}
 m   
20:21 (cur | prev) +116 Jwarner talk contribs →‎VEBEP {{#subobject:d7a2a6|Regimen=1}}
 m   20:04  Endometrial cancer diffhist +3 Jwarner talk contribs
 m   19:20  Prostate cancer diffhist +137 Jwarner talk contribs
     18:59  Non-small cell lung cancer, squamous‎‎ 2 changes history +4,715 [Jwarner‎ (2×)]
 m   
18:59 (cur | prev) +2,641 Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf|Regimen=1}}
     
18:54 (cur | prev) +2,074 Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Pembrolizumab {{#subobject:1dc8a3|Regimen=1}}
 m   18:47  Hepatocellular carcinoma diffhist +2,076 Jwarner talk contribs
 m   17:07  Medulloblastoma diffhist +55 Jwarner talk contribs →‎Consolidation
 m   17:00  HIV-associated lymphoma diffhist -24 Jwarner talk contribs →‎CNS therapy, prophylaxis {{#subobject:724xbj|Variant=1}}
 m   16:52  Ewing sarcoma, pediatric‎‎ 2 changes history -69 [Jwarner‎ (2×)]
 m   
16:52 (cur | prev) +11 Jwarner talk contribs
 m   
16:51 (cur | prev) -80 Jwarner talk contribs →‎COG AEWS1031 Regimen A
 m   16:40  Burkitt lymphoma diffhist -25 Jwarner talk contribs
 m   10:57  Head and neck cancer diffhist +1,139 Jwarner talk contribs →‎Cisplatin & RT {{#subobject:c7061f|Regimen=1}}
 m   10:45  Breast cancer, HER2-positive diffhist +1,725 Jwarner talk contribs
 m   10:42  Cholangiocarcinoma diffhist +1,080 Jwarner talk contribs

2 May 2024

 m   00:05  Pyruvate kinase deficiency diffhist +634 Jwarner talk contribs

1 May 2024

 m   20:14  Ovarian cancer diffhist +3 Jwarner talk contribs →‎Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab {{#subobject:a38gbb|Regimen=1}}
 m   15:53  Nasopharyngeal carcinoma diffhist +6 Jwarner talk contribs
 m   13:47  Breast cancer diffhist -167 Jwarner talk contribs →‎AC-T {{#subobject:633n67|Regimen=1}}

30 April 2024

 m   22:54  Follicular lymphoma diffhist +751 Jwarner talk contribs →‎References
 m   19:46  Breast cancer, HER2-positive diffhist +1,008 Jwarner talk contribs
     17:35  Multiple myeloma, relapsed-refractory‎‎ 2 changes history +1,926 [Jwarner‎ (2×)]
     
17:35 (cur | prev) +1,912 Jwarner talk contribs →‎VTD {{#subobject:96881b|Regimen=1}}
 m   
17:27 (cur | prev) +14 Jwarner talk contribs →‎Regimen variant #2 {{#subobject:fc94h1|Variant=1}}
 m   13:11  Soft tissue sarcoma‎‎ 4 changes history +1,765 [Jwarner‎ (4×)]
 m   
13:11 (cur | prev) 0 Jwarner talk contribs →‎Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}}
 m   
13:07 (cur | prev) +1,701 Jwarner talk contribs →‎Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}}
 m   
12:58 (cur | prev) +44 Jwarner talk contribs →‎References
 m   
11:33 (cur | prev) +20 Jwarner talk contribs →‎Cisplatin monotherapy {{#subobject:6e93fa|Regimen=1}}
 m   11:31  Desmoid tumor‎‎ 2 changes history +12 [Jwarner‎ (2×)]
 m   
11:31 (cur | prev) +19 Jwarner talk contribs
 m   
11:29 (cur | prev) -7 Jwarner talk contribs →‎Nirogacestat monotherapy {{#subobject:f3agdc|Regimen=1}}
 m   11:27  Breast cancer, triple negative‎‎ 6 changes history +161 [Jwarner‎ (6×)]
 m   
11:27 (cur | prev) +86 Jwarner talk contribs
 m   
11:05 (cur | prev) +2 Jwarner talk contribs →‎References
 m   
11:04 (cur | prev) +25 Jwarner talk contribs →‎Carboplatin & Gemcitabine (GCb) {{#subobject:d46b34|Regimen=1}}
 m   
11:03 (cur | prev) +2 Jwarner talk contribs →‎References
 m   
11:02 (cur | prev) +2 Jwarner talk contribs →‎References
 m   
11:01 (cur | prev) +44 Jwarner talk contribs →‎References